| 1. |
Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet, 2014, 383(9916): 549-557.
|
| 2. |
Budhu A, Forgues M, Ye QH, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell, 2006, 10(2): 99-111.
|
| 3. |
Coffelt SB, de Visser KE. Cancer: Inflammation lights the way to metastasis. Nature, 2014, 507(7490): 48-49.
|
| 4. |
Barton MK. Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence. CA Cancer J Clin, 2015, 65(2): 83-84.
|
| 5. |
Rankin EB, Giaccia AJ. Hypoxic control of metastasis. Science, 2016, 352(6282): 175-180.
|
| 6. |
Wang WQ, Liu L, Sun HC, et al. TanshinoneⅡA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization. J HematolOncol, 2012, 5: 69.
|
| 7. |
Ye QH, Qin LX, Forgues M, et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med, 2003, 9(4): 416-423.
|
| 8. |
Clark JW, Chabner BA. Limits to precision cancer medicine. N Engl J Med, 2017, 376(1): 96.
|
| 9. |
Cole SW, Nagaraja AS, Lutgendorf SK, et al. Sympathetic nervous system regulation of the tumour microenvironment. Nat Rev Cancer, 2015, 15(9): 563-572.
|
| 10. |
Boilly B, Faulkner S, Jobling P, et al. Nerve dependence: from regeneration to cancer. Cancer Cell, 2017, 31(3): 342-354.
|
| 11. |
Spitzer MH, Carmi Y, Reticker-Flynn NE, et al. Systemic immunity is required for effective cancer immunotherapy. Cell, 2017, 168(3): 487-502.
|
| 12. |
Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet, 2013, 381(9869): 805-816.
|
| 13. |
Chang CH, Qiu J, O’Sullivan D, et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell, 2015, 162(6): 1229-1241.
|
| 14. |
Geiger R, Rieckmann JC, Wolf T, et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell, 2016, 167(3): 829-842.
|
| 15. |
Bu Y, Jia QA, Ren ZG, et al. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells. Oncotarget, 2015, 6(37): 40068-40080.
|
| 16. |
Zhang QB, Meng XT, Jia QA, et al. Herbal compound Songyou Yin and moderateswimming suppress growth and metastasis of liver cancer by enhancing immune function. Integr Cancer Ther, 2016, 15(3): 368-375.
|
| 17. |
Jia QA, Ren ZG, Bu Y, et al. Herbal compound " Songyou Yin” renders hepatocellular carcinoma sensitive to oxaliplatin through inhibition of stemness. Evid Based Complement Alternat Med, 2012, 2012: 908601.
|
| 18. |
Zhang QB, Zhang BH, Zhang KZ, et al. Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system. Oncogene, 2016, 35(31): 4122-4131.
|
| 19. |
Yan Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell, 2015, 160(1-2): 62-73.
|
| 20. |
Cole SW. Nervous system regulation of the cancer genome. Brain BehavImmun, 2013, 30 Suppl: S10-S18.
|
| 21. |
Komarova NL. Cancer: a moving target. Nature, 2015, 525(7568): 198-199.
|
1/5
WeChat